Health&Beauty Bayer sells a facility at its Wuppertal site to WuXi Biologics The FINANCIAL -- Companies to also enter into long-term sublease agreement and service contract / Buyer planning to use facility to produce COVID-19 vaccine and other biologics More by The FINANCIAL December 22, 2020 1 min read